BeOne Medicines AG (6160.HK) HKSE
164.90
-3.9(-2.31%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
164.90
-3.9(-2.31%)
Currency In HKD
| Market Cap | 32.66B |
| Enterprise Value | 29.16B |
| P/E Ratio | 59.26 |
| PEG Ratio | 0.02 |
| Price/Sales Ratio | 4.95 |
| Price/Book Ratio | 6.37 |
| Enterprise/Revenue | 4.47 |
| Enterprise/EBITDA | 30.67 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.09 |
| Operating Margin | 0.12 |
| Return On Assets | 0.06 |
| Return On Equity | 0.12 |
| Revenue | 5.35B |
| Revenue/Share | 3.97 |
| Gross Profit | 4.56B |
| EBITDA | 589.69M |
| Net Income | 287.36M |
| Diluted EPS | 0.2 |
| Total Cash | 4.83B |
| Total Cash/Share | 3.35 |
| Total Debt | 2.05B |
| Total Debt/Equity | 0.43 |
| Current Ratio | 3.64 |
| Book Value Per Share | 3.32 |
| 52-Week Change | 12.1 |
| 52-Week High | 229.4 |
| 52-Week Low | 144.1 |
| Moving Average 50 Days | 181.54 |
| Moving Average 200 Days | 192.22 |
| Average Volume | 4.13M |
| Shares Outstanding | 1.35B |
| % Held by Institutions | 0.01 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |